S&P 500   3,931.34 (-1.69%)
DOW   33,505.15 (-1.30%)
QQQ   281.87 (-2.01%)
AAPL   143.68 (-2.01%)
MSFT   245.00 (-2.08%)
META   114.75 (-6.27%)
GOOGL   97.39 (-2.10%)
AMZN   88.72 (-2.52%)
TSLA   178.11 (-2.38%)
NVDA   160.19 (-3.56%)
NIO   13.01 (+1.64%)
BABA   91.21 (+0.76%)
AMD   70.70 (-3.97%)
T   19.00 (+1.33%)
MU   53.61 (-0.80%)
CGC   3.61 (-16.44%)
F   13.08 (-2.24%)
GE   84.97 (+0.37%)
DIS   92.89 (-3.17%)
AMC   6.73 (-9.66%)
PYPL   72.01 (-2.19%)
PFE   49.31 (-2.80%)
NFLX   305.45 (-2.28%)
S&P 500   3,931.34 (-1.69%)
DOW   33,505.15 (-1.30%)
QQQ   281.87 (-2.01%)
AAPL   143.68 (-2.01%)
MSFT   245.00 (-2.08%)
META   114.75 (-6.27%)
GOOGL   97.39 (-2.10%)
AMZN   88.72 (-2.52%)
TSLA   178.11 (-2.38%)
NVDA   160.19 (-3.56%)
NIO   13.01 (+1.64%)
BABA   91.21 (+0.76%)
AMD   70.70 (-3.97%)
T   19.00 (+1.33%)
MU   53.61 (-0.80%)
CGC   3.61 (-16.44%)
F   13.08 (-2.24%)
GE   84.97 (+0.37%)
DIS   92.89 (-3.17%)
AMC   6.73 (-9.66%)
PYPL   72.01 (-2.19%)
PFE   49.31 (-2.80%)
NFLX   305.45 (-2.28%)
S&P 500   3,931.34 (-1.69%)
DOW   33,505.15 (-1.30%)
QQQ   281.87 (-2.01%)
AAPL   143.68 (-2.01%)
MSFT   245.00 (-2.08%)
META   114.75 (-6.27%)
GOOGL   97.39 (-2.10%)
AMZN   88.72 (-2.52%)
TSLA   178.11 (-2.38%)
NVDA   160.19 (-3.56%)
NIO   13.01 (+1.64%)
BABA   91.21 (+0.76%)
AMD   70.70 (-3.97%)
T   19.00 (+1.33%)
MU   53.61 (-0.80%)
CGC   3.61 (-16.44%)
F   13.08 (-2.24%)
GE   84.97 (+0.37%)
DIS   92.89 (-3.17%)
AMC   6.73 (-9.66%)
PYPL   72.01 (-2.19%)
PFE   49.31 (-2.80%)
NFLX   305.45 (-2.28%)
S&P 500   3,931.34 (-1.69%)
DOW   33,505.15 (-1.30%)
QQQ   281.87 (-2.01%)
AAPL   143.68 (-2.01%)
MSFT   245.00 (-2.08%)
META   114.75 (-6.27%)
GOOGL   97.39 (-2.10%)
AMZN   88.72 (-2.52%)
TSLA   178.11 (-2.38%)
NVDA   160.19 (-3.56%)
NIO   13.01 (+1.64%)
BABA   91.21 (+0.76%)
AMD   70.70 (-3.97%)
T   19.00 (+1.33%)
MU   53.61 (-0.80%)
CGC   3.61 (-16.44%)
F   13.08 (-2.24%)
GE   84.97 (+0.37%)
DIS   92.89 (-3.17%)
AMC   6.73 (-9.66%)
PYPL   72.01 (-2.19%)
PFE   49.31 (-2.80%)
NFLX   305.45 (-2.28%)
NASDAQ:ALXO

ALX Oncology - ALXO Earnings Date, Estimates & Call Transcripts

$10.77
-1.07 (-9.04%)
(As of 12/6/2022 01:13 PM ET)
Add
Compare
Today's Range
$10.60
$11.50
50-Day Range
$9.48
$12.89
52-Week Range
$5.82
$34.42
Volume
3,402 shs
Average Volume
141,875 shs
Market Capitalization
$438.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$35.67
Skip Charts & View Estimated and Actual Earnings Data

ALXO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALXO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ALX Oncology Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20222($0.91)($0.64)($0.78)
Q2 20222($0.67)($0.66)($0.67)
Q3 20222($0.72)($0.69)($0.71)
Q4 20223($0.91)($0.64)($0.75)
FY 20229($3.21)($2.63)($2.90)
Q1 20233($0.90)($0.65)($0.75)
Q2 20233($0.91)($0.69)($0.79)
Q3 20233($0.92)($0.72)($0.82)
Q4 20233($0.93)($0.87)($0.89)
FY 202312($3.66)($2.93)($3.25)

ALXO Earnings Date and Information

ALX Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 27th, 2023 based off prior year's report dates.

ALX Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/27/2023
(Estimated)
        
8/8/2022Q2 2022($0.66)($0.81)($0.15)($0.81)
5/9/2022Q1 2022($0.77)($0.60)+$0.17($0.60)
2/28/2022Q4 2021($0.77)($0.70)+$0.07($0.70)
11/11/20219/30/2021($0.48)($0.61)($0.13)($0.61)
8/11/20216/30/2021($0.44)($0.40)+$0.04($0.40)    
5/16/20213/31/2021($0.41)($0.35)+$0.06($0.35)
3/18/202112/31/2020($0.35)($0.48)($0.13)($0.46)
11/17/2020Q3($0.36)($0.35)+$0.01($0.34)  
8/27/2020Q2 2020($0.29)($4.28)($3.99)($4.15)$0.60 million$0.53 million












ALX Oncology Earnings - Frequently Asked Questions

When is ALX Oncology's earnings date?

ALX Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 27th, 2023 based off last year's report dates. Learn more on ALXO's earnings history.

How much revenue does ALX Oncology generate each year?

ALX Oncology (NASDAQ:ALXO) has a recorded annual revenue of $1.18 million.

How much profit does ALX Oncology generate each year?

ALX Oncology (NASDAQ:ALXO) has a recorded net income of -$83.46 million. ALXO has generated -$2.98 earnings per share over the last four quarters.

What is ALX Oncology's EPS forecast for next year?

ALX Oncology's earnings are expected to decrease from ($3.17) per share to ($3.61) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:ALXO) was last updated on 12/6/2022 by MarketBeat.com Staff